{"id":"W4414857438","doi":"10.1093/oncolo/oyaf330","title":"Management of Canadian patients with refractory or relapsed diffuse large B-cell lymphoma in the real world: a subanalysis of the RE-MIND2 study","year":2025,"lang":"en","type":"article","venue":"The Oncologist","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"Daiichi Sankyo Europe; U.S. Food and Drug Administration; Celgene; MorphoSys; Gilead Sciences; Kite Pharma; Incyte; BeiGene; TG Therapeutics; Seagen; Karyopharm Therapeutics; AstraZeneca","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Lymphoma; Standard of care; Salvage therapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001542103,0.0001497378,0.0003925585,0.0005367419,0.000141489,0.00001340004,0.0007379623,0.00005598989,0.0002581533],"category_scores_gemma":[0.000069513,0.00006035599,0.0001023201,0.00308259,0.0002872572,0.00002120807,0.0001546081,0.000256214,0.000003251109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006703574,"about_ca_system_score_gemma":0.0005282476,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1086641,"about_ca_topic_score_gemma":0.7321883,"domain_scores_codex":[0.997788,0.0006089992,0.0003977272,0.0002392574,0.0006201856,0.0003458864],"domain_scores_gemma":[0.9979529,0.0003997476,0.0001860763,0.00128129,0.000120956,0.00005897928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004770807,0.01735776,0.9565137,0.0001719666,0.0008777835,0.0002388194,0.005783802,0.000009310002,0.0001195742,0.0002891616,0.003214068,0.01065324],"study_design_scores_gemma":[0.01561214,0.001112129,0.9563366,0.000113575,0.0004990515,4.087946e-7,0.01177747,0.00002276835,0.0001305719,0.00001756255,0.01430362,0.00007417145],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9283538,0.00003842101,6.987781e-7,0.001628838,0.00005156543,0.001958709,0.00001945921,0.000007042499,0.06794145],"genre_scores_gemma":[0.9643642,0.0001013899,0.00002038417,0.0003381266,0.00001361945,0.0001081396,0.000009269563,0.00001402355,0.0350309],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6235243,"threshold_uncertainty_score":0.8972715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02572095470819502,"score_gpt":0.3219684897978651,"score_spread":0.2962475350896701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}